Self-emulsifying formulations of CETP inhibitors
US8486983B2 · kind B2 · utility
7Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2006 |
| Grant date | Jul 16, 2013 |
| Priority date | — |
| Expiry date | Dec 5, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A liquid formulation for oral administration of the CETP inhibitor of formula (I) has improved bioavailability compared with conventional solid formulations. The formulation comprises the CETP inhibitor, or a pharmaceutically acceptable salt thereof; an oil; and one or more nonionic surfactants having a hydrophilic lipophilic balance (HLB)>10.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.